malondialdehyde has been researched along with Ophthalmoplegia, Progressive Supranuclear in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albers, DS; Augood, SJ; Beal, MF; Martin, DM; Standaert, DG; Vonsattel, JP | 1 |
| Adamson, J; Albers, DS; Augood, SJ; Beal, MF; Browne, SE; Gibson, GE; Hutton, M; Martin, DM; Park, LC; Standaert, DG; Vonsattel, JP | 1 |
2 other study(ies) available for malondialdehyde and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Free Radicals; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nerve Degeneration; Oxidative Stress; Supranuclear Palsy, Progressive; Thalamic Nuclei | 1999 |
Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment.
Topics: Aged; Aged, 80 and over; Cadaver; Female; Frontal Lobe; Glutamate Dehydrogenase; Humans; Ketoglutarate Dehydrogenase Complex; Male; Malondialdehyde; Middle Aged; Mitochondria; Oxidative Stress; Reference Values; Supranuclear Palsy, Progressive | 2000 |